Compare · DXCM vs XRAY
DXCM vs XRAY
Side-by-side comparison of DexCom Inc. (DXCM) and DENTSPLY SIRONA Inc. (XRAY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DXCM and XRAY operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- DXCM is the larger of the two at $22.98B, about 9.8x XRAY ($2.35B).
- Over the past year, DXCM is down 16.6% and XRAY is down 15.6% - XRAY leads by 1.0 points.
- DXCM has been more active in the news (8 items in the past 4 weeks vs 5 for XRAY).
- Both have 25 recent analyst ratings on file.
- Company
- DexCom Inc.
- DENTSPLY SIRONA Inc.
- Price
- $59.53+3.39%
- $11.74+2.35%
- Market cap
- $22.98B
- $2.35B
- 1M return
- -5.19%
- +1.12%
- 1Y return
- -16.59%
- -15.60%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2005
- 1987
- News (4w)
- 8
- 5
- Recent ratings
- 25
- 25
DexCom Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
Latest DXCM
- SEC Form 10-Q filed by DexCom Inc.
- DexCom Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Dexcom Reports First Quarter 2026 Financial Results
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
- SEC Form 4 filed by Brown Michael Jon
- SEC Form DEFA14A filed by DexCom Inc.
- SEC Form DEF 14A filed by DexCom Inc.
- SEC Form 144 filed by DexCom Inc.
- Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
- Amendment: SEC Form SCHEDULE 13G/A filed by DexCom Inc.
Latest XRAY
- Wellspect HealthCare Expands Surity™ Portfolio in the U.S. with Surity™ Male External Catheter for Urinary Incontinence Care
- SEC Form DEFA14A filed by DENTSPLY SIRONA Inc.
- SEC Form DEF 14A filed by DENTSPLY SIRONA Inc.
- Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5
- Citigroup initiated coverage on Dentsply Sirona with a new price target
- SEC Form 4 filed by Mazelsky Jonathan Jay
- Amendment: SEC Form SCHEDULE 13G/A filed by DENTSPLY SIRONA Inc.
- SEC Form 4 filed by President, CEO & Member of BOD Scavilla Daniel T
- SEC Form 4 filed by EVP, Chief Commercial Officer Denti Aldo Mariano Roberto
- SEC Form 4 filed by VP, Chief Accounting Officer Czerney Kevin